By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Lymphedema products72.38M84.40%
Airway clearance products13.37M15.60%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States292.98M100.00%